Open terminalDashboard

Last updated Nov 18, 8:48 AM ET · 1 update

Thermo Fisher launches new cell culture medium for vaccine production

Thermo Fisher Scientific unveiled a new Gibco medium aimed at adenovirus vaccine manufacturing, the company said Wednesday.

  1. Thermo Fisher Scientific announced Wednesday morning the launch of its Gibco VaxEvo CD 293 Medium, a cell culture formula built to support adenovirus vaccine manufacturing, according to the company's release carried by Business Wire.

What happened

Thermo Fisher Scientific said in a release distributed by Business Wire that it has launched the Gibco VaxEvo CD 293 Medium, an animal origin-free formulation with defined chemical composition for growing suspension HEK293 cells used in making high-titer adenovirus. The company described the product as available in both liquid and AGT formats, intended to serve vaccine developers starting from early-stage process work. Business Wire's distribution of the announcement is the only report on the launch so far.

How the stock has moved

TMO traded at $684.98 in pre-market trading, down 0.26% from Tuesday's close of $686.79, a move that has held steady since the announcement was first reported.

Thermo Fisher Scientific (TMO) since the news
MeasureValue
Price, pre-market trading$684.98
Since the close before the first report (Tuesday, November 17, 2026)-0.26%
Change from the close on Tuesday, November 17, 2026-0.26%
Market value at the close on Tuesday, November 17, 2026$254.47 billion

Source: Stock quote; the close before the first report from our saved closes · as of November 18, 2026 at 8:48 AM ET · Shows what the stock did after the news was first reported, not why.

Its suppliers and customers

Among companies named in Thermo Fisher's filings, customers Bio-Techne and Bayer, along with supplier Sanofi, show mixed moves in trading outside the regular session, while customers Solventum and Idexx Laboratories are lower; Federal Express, DHL and Solventa show no trades since their last close.

Suppliers and customers of Thermo Fisher Scientific, and how they are trading
CompanyRoleStockSince last close
Bio-TechneCustomerTECH+0.22%
SolventumCustomerSOLV-1.10%
Idexx LaboratoriesCustomerIDXX-0.56%
SanofiSupplierSNY-0.13%
Federal ExpressSupplierNot listed—
DHLSupplierNot listed—
SolventaSupplierNot listed—
BayerCustomerNot listed—

Source: Relationships named in company filings (SEC 10-K annual report; Earnings call transcript); stock quotes · as of November 18, 2026 at 8:48 AM ET · A supplier or customer moving the same day is not evidence that one move caused the other.

Sources

  • — Business Wire

How this was made

Written from WiseView data and the sources credited above, and checked before it went up. It is updated as new reports come in, and every update is checked before it goes up. How this report is made

For information only, not investment advice.

More from the desk

Follow SOLV, IDXX and TECH in the terminal.

Every panel, HootAI, the squawk and the pre-market board, on one membership.

Annual

$83/mo

Billed annually, $997 once a year.

Monthly

$127/mo

Billed monthly. Cancel any time.

14-day free trial · no card needed · nothing to cancel. Buying for a team? Seats on one invoice.